top of page
Latest News from Pro PG


Pro PG receives S19A RoActemra tocilizumab 162mg/0.9mL PFS and PENS
Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position. For current Australian shortage and supply information, see medicine shortages in Australia. Pro Pharmaceuticals Group has arranged for the supply of the following overseas registered tocilizumab products on a temporar
Sep 22, 2021


Pro PG receives S19A for RoActemra (tocilizumab) Vials
Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position. For current Australian shortage and supply information, see medicine shortages in Australia. Pro Pharmaceuticals Group has arranged for the supply of the following overseas registered tocilizumab products on a temporar
Sep 14, 2021
bottom of page